2 January 2025 Transparency Directive Voting rights and capital The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. As at 31 December 2024 the issued share capital of AstraZeneca PLC with voting rights is 1,550,546,239 ordinary shares of US$0.25. No shares …
